1. Home
  2. TEVA vs CCJ Comparison

TEVA vs CCJ Comparison

Compare TEVA & CCJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • CCJ
  • Stock Information
  • Founded
  • TEVA 1901
  • CCJ 1987
  • Country
  • TEVA Israel
  • CCJ Canada
  • Employees
  • TEVA N/A
  • CCJ N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • CCJ Other Metals and Minerals
  • Sector
  • TEVA Health Care
  • CCJ Basic Materials
  • Exchange
  • TEVA Nasdaq
  • CCJ Nasdaq
  • Market Cap
  • TEVA 23.7B
  • CCJ 22.5B
  • IPO Year
  • TEVA N/A
  • CCJ N/A
  • Fundamental
  • Price
  • TEVA $21.83
  • CCJ $53.55
  • Analyst Decision
  • TEVA Buy
  • CCJ Strong Buy
  • Analyst Count
  • TEVA 7
  • CCJ 4
  • Target Price
  • TEVA $22.43
  • CCJ $66.56
  • AVG Volume (30 Days)
  • TEVA 8.9M
  • CCJ 3.2M
  • Earning Date
  • TEVA 01-29-2025
  • CCJ 02-20-2025
  • Dividend Yield
  • TEVA N/A
  • CCJ 0.21%
  • EPS Growth
  • TEVA N/A
  • CCJ N/A
  • EPS
  • TEVA N/A
  • CCJ 0.19
  • Revenue
  • TEVA $16,772,000,000.00
  • CCJ $2,069,888,595.00
  • Revenue This Year
  • TEVA $5.74
  • CCJ $17.40
  • Revenue Next Year
  • TEVA $4.46
  • CCJ $10.47
  • P/E Ratio
  • TEVA N/A
  • CCJ $278.00
  • Revenue Growth
  • TEVA 9.81
  • CCJ 23.31
  • 52 Week Low
  • TEVA $11.48
  • CCJ $35.43
  • 52 Week High
  • TEVA $22.80
  • CCJ $62.55
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 60.46
  • CCJ 54.08
  • Support Level
  • TEVA $21.21
  • CCJ $48.78
  • Resistance Level
  • TEVA $22.10
  • CCJ $50.48
  • Average True Range (ATR)
  • TEVA 0.62
  • CCJ 1.90
  • MACD
  • TEVA -0.11
  • CCJ 0.20
  • Stochastic Oscillator
  • TEVA 69.42
  • CCJ 67.23

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About CCJ Cameco Corporation

Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. Cameco has three reportable segments, uranium, fuel services and Westinghouse. It derives maximum revenue from Uranium Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia and United States.

Share on Social Networks: